ABSTRACT
Developmental failure, intractable seizures, progressive loss of cerebral white matter, hypouricemia, elevated urinary S-sulfocysteine, loss of activity of xanthine oxidase, sulfate oxidase, and aldehyde oxidase; and mutations in MOCSIA, MOCSIB, MOCS2A, and the gene for gephyrin, GEPH.
